July 2017: Change of Mind (Phase II) working with mental health service delivery organisations

May 2017: Change of Mind campaign (Phase I) commenced encouraging hep C treatment in mental health settings

September 2016: Treatment for all campaign encouraged PBAC submissions in support of Epclusa, Harvoni (for all genotypes) and Technivie

March 2016: Treatment has changed campaign promoted the commencement of universal access to Direct Acting Antivirals to cure HCV for all Australians regardless of disease progression, treatment history or substance use history.

January 2016: Nobody left behind campaign encouraged PBAC submissions in support of grazoprevir + elbasvir for people with HCV who have: not responded to previous treatment; liver cirrhosis; HIV co-infection; or kidney disease

December 2015: ETA campaign concluded with the submission of petition to Health Minister in November and announcement of PBS access on 21 December

September 2015: Time for New Cures social media campaign to urge the Federal Health Minister to sign Direct Acting Antivirals into legislation

July 2015: Time for Action campaign for NSW Hepatitis Awareness Week and World Hepatitis Day

June 2015: ETA campaign Phase 4 comprised support for PBAC submissions on Viekira Pak for the July 2015 PBAC meeting

March 2015: Hepatitis Matters campaign encouraged community members to review responses by major parties to key hepatitis issues before voting. C me Community Advocates send letters to candidates in their electorates

February 2015: Hep C Matters campaign facilitated written submissions to the Parliamentary inquiry into Hepatitis C

January 2015: ETA campaign Phase 3 encouraged PBAC submissions in support of sofosbuvir, sofosbuvir+ledipasvir, asanuprevir and daclatasvir. for the March PBAC meeting

November 2014: ETA Phase 2 launched an online petition targeting Australian Health Minister.

June 2014: Equal Treatment Access (ETA) Phase 1 commenced with the C me Community Advocates leading the broader affected community to make submissions to PBAC regarding sofosbuvir and simeprevir.

• Mental Health Coordinating Council, BEING, WayAhead, Mental Health Carers NSW, NADA
• Other state and territory hepatitis organisations
• Other blood borne virus sector organisations in NSW
• Primary Health Regions
• Local Health Districts
• Members of Hepatitis NSW

Planning advocacy campaign based on current priorities and external events. Campaigns are designed with a strong visual and catchy slogan to ensure engagement with members of the affected community and an effective result.

Change of Mind campaign (Phase II) to target mental health service delivery organisations in HY2 2017

Continue to plan two advocacy campaigns per year, acknowledging that campaigns may overlap and have several phases.